42 CHAPTER 3 FUNDING This study did not receive funding. The CAPACITY-COVID registry is supported by the Dutch Heart Foundation (2020B006 CAPACITY), the EuroQol Research Foundation, Novartis Global, Sanofi Genzyme Europe, Novo Nordisk Nederland, Servier Nederland, and Daiichi Sankyo Nederland. The Dutch Network for Cardiovascular Research (WCN), a partner within the CAPACITY-COVID consortium, received funding from the Dutch Heart Foundation (2020B006 CAPACITY) for site management and logistic support in the Netherlands. JO is supported by a PhD scholarship from the AMC graduate school. ML is supported by the Alexandre Suerman Stipend of the University Medical Center Utrecht. AW and CAR are supported by the CardioVascularResearch Initiative CVON (Dutch Heart Foundation, Dutch Federation of University Medical Centres, ZonMw, and the Royal Netherlands Academy of Sciences; PREDICT2 CVON2018-30). GJG is supported by a VENI and VIDI grant from the Netherlands Organisation for Health Research and Development (ZonMw numbers 016.166.030 and 016.196.304). POTENTIAL CONFLICTS OF INTEREST FR and GJG report unrestricted institutional grants for performing research in the field of atrial fibrillation from Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb/Pfizer Alliance and Daiichi Sankyo. The other authors declare that they have no conflicts of interest. CONTRIBUTORS LJ, JO, GJG and CAR conceived and initiated the study. LJ and JO prepared the dataset. LJ, JO and MvS performed the statistical analyses. LJ, JO, MvS, ML, GJG and CAR interpreted the results. LJ, JO, GJG and CAR wrote the first version of the manuscript. All authors critically reviewed and revised the manuscript. ACKNOWLEDGEMENT We express our gratitude to all participating sites and researchers part of the CAPACITYCOVID collaborative consortium. CAPACITY-COVID gratefully acknowledges the following organizations for their assistance in the development of the registry and/ or coordination regarding the data registration in the collaborating centres: partners of the Dutch CardioVascular Alliance (DCVA), the Dutch Association of Medical Specialists (FMS), and the British Heart Foundation Centres of Research Excellence.
RkJQdWJsaXNoZXIy MTk4NDMw